BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28713192)

  • 1.
    Banin Hirata BK; Losi Guembarovski R; Vitiello GAF; Guembarovski AL; Brajão de Oliveira K; Watanabe MAE
    Dis Markers; 2017; 2017():6359603. PubMed ID: 28713192
    [No Abstract]   [Full Text] [Related]  

  • 2. Transforming growth factor beta 1 (TGFβ1) polymorphisms and haplotype structures have dual roles in breast cancer pathogenesis.
    Vitiello GAF; Guembarovski RL; Hirata BKB; Amarante MK; de Oliveira CEC; de Oliveira KB; Cebinelli GCM; Guembarovski AL; Campos CZ; Watanabe MAE
    J Cancer Res Clin Oncol; 2018 Apr; 144(4):645-655. PubMed ID: 29362917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
    Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H
    Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
    Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
    Anticancer Res; 2015 Nov; 35(11):5901-4. PubMed ID: 26504013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 7 receptor alpha Thr244Ile genetic polymorphism is associated with susceptibility and prognostic markers in breast cancer subgroups.
    Vitiello GAF; Losi Guembarovski R; Amarante MK; Ceribelli JR; Carmelo ECB; Watanabe MAE
    Cytokine; 2018 Mar; 103():121-126. PubMed ID: 28964592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FoxP3 gene polymorphism is associated with breast cancer in Iranian patients.
    Arabpour F; Shafizad A; Rahimzadeh M; Norouzan M; Naderi N
    Exp Oncol; 2018 Dec; 40(4):309-314. PubMed ID: 30593749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta receptor II (TGFBR2) promoter region polymorphism in Brazilian breast cancer patients: association with susceptibility, clinicopathological features, and interaction with TGFB1 haplotypes.
    Vitiello GAF; Amarante MK; Banin-Hirata BK; Campos CZ; de Oliveira KB; Losi-Guembarovski R; Watanabe MAE
    Breast Cancer Res Treat; 2019 Nov; 178(1):207-219. PubMed ID: 31364002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological grade as an alternative to the Ki67 labeling index is only available for luminal-type breast cancers.
    Hayashi S; Kitada M; Sato K; Matsuda Y; Ishibashi K; Oikawa K; Miyokawa N; Hirata S
    Breast Cancer; 2014 Jan; 21(1):47-51. PubMed ID: 22467403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between rs61764370, rs9266, and rs140080026 polymorphisms of the KRAS gene and breast cancer risk in a Mexican population.
    Gallegos-Arreola MP; García Verdín PM; Magaña-Torres MT; Figuera LE; Zúñiga-González GM; Rosales-Reynoso MA; Gómez-Meda BC; Puebla-Pérez AM
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6454-6464. PubMed ID: 34787849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single nucleotide polymorphisms in the FOXP3 gene are associated with increased risk of relapsing-remitting multiple sclerosis.
    Eftekharian MM; Sayad A; Omrani MD; Ghannad MS; Noroozi R; Mazdeh M; Mirfakhraie R; Movafagh A; Roshanaei G; Azimi T; Inoko H; Taheri M
    Hum Antibodies; 2016; 24(3-4):85-90. PubMed ID: 27792007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment.
    Jwa E; Shin KH; Kim JY; Park YH; Jung SY; Lee ES; Park IH; Lee KS; Ro J; Kim YJ; Kim TH
    Cancer Res Treat; 2016 Oct; 48(4):1363-1372. PubMed ID: 26910473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of aplastic anemia and FoxP3 gene polymorphisms in Koreans.
    In JW; Lee N; Roh EY; Shin S; Park KU; Song EY
    Hematology; 2017 Apr; 22(3):149-154. PubMed ID: 27702400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
    Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
    Anticancer Res; 2015 Dec; 35(12):6667-70. PubMed ID: 26637882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional SNP in stem of mir-146a affects Her2 status and breast cancer survival.
    Meshkat M; Tanha HM; Naeini MM; Ghaedi K; Sanati MH; Meshkat M; Bagheri F
    Cancer Biomark; 2016 Jul; 17(2):213-22. PubMed ID: 27434289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association between body mass index and immunohistochemical subtypes in breast cancer.
    Sahin S; Erdem GU; Karatas F; Aytekin A; Sever AR; Ozisik Y; Altundag K
    Breast; 2017 Apr; 32():227-236. PubMed ID: 27756509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between HER2 and IL-6 genes polymorphisms and clinicopathological characteristics of breast cancer: significant role of genetic variability in specific breast cancer subtype.
    Bouhniz OE; Zaied S; Naija L; Bettaieb I; Rahal K; Driss M; Kenani A
    Clin Exp Med; 2020 Aug; 20(3):427-436. PubMed ID: 32372374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism rs4919510:C>G in mature sequence of human microRNA-608 contributes to the risk of HER2-positive breast cancer but not other subtypes.
    Huang AJ; Yu KD; Li J; Fan L; Shao ZM
    PLoS One; 2012; 7(5):e35252. PubMed ID: 22586447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of HLA-G +3142 C>G polymorphism and breast cancer in Tunisian population.
    Zidi I; Dziri O; Zidi N; Sebai R; Boujelebene N; Ben Hassine A; Ben Yahia H; Laaribi AB; Babay W; Rifi H; Mezlini A; Chelbi H
    Immunol Res; 2016 Aug; 64(4):961-8. PubMed ID: 26754763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
    Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women.
    Crispo A; Montella M; Buono G; Grimaldi M; D'Aiuto M; Capasso I; Esposito E; Amore A; Nocerino F; Augustin LS; Giudice A; Di Bonito M; Giuliano M; Forestieri V; De Laurentiis M; Rinaldo M; Ciliberto G; De Placido S; Arpino G
    Curr Res Transl Med; 2016; 64(1):15-20. PubMed ID: 27140595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.